Ⅰ. Introduction
Nitric oxide (NO) is a short-lived bioactive molecule produced by immunocompetent cells such as macrophages that serves as a messenger molecule for various physiological and pathological processes 1) . It is synthesized from L-arginine by nitric oxide synthase (NOS) present in various tissues 2) . Three distinct isoforms of NOS, neural (nNOS), endothelial (eNOS) and inducible (iNOS), have been reported in mammalian tissues 2) . Expression of iNOS, also commonly called NOS-2, is induced by inflammatory stimuli such as bacterial lipopolysaccharide (LPS), and proinflammatory cytokines such as tumor necrosis factor alpha (TNF-α), interleukin-1β (IL-1β), and interferon-γ (IFN-γ), in a variety of cell types including macrophages, following bacterial infection 3, 4) . iNOS, once expressed, can generate large amounts of NO for extended times, and is believed to be involved in cytotoxic effects following inflammation 1) . 1) Periodontal disease is a chronic inflammatory process accompanied by destruction of surrounding connective tissue and alveolar bone, and sometimes loss of teeth 5) . The *This study was supported by a grant of the Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea (03-PJ1-PG1-CH08-0001). *Corresponding author: Sung-Jo Kim, Department of Periodontology, College of Dentistry, Pusan National University. 1-10 Ami-Dong, Seo-Ku, Busan 602-739, South Korea, Phone: +82-51-240-7461 Fax: +82-51-245-8388, E-mail: sungjokim@pusan.ac.kr primary causative agents of periodontal disease are particular gram-negative anaerobic bacteria that accumulate in the gingival sulcus. Porphyromonas gingivalis is a major periodontal pathogen that is dominant in the periodontal pockets of patients with adult periodontitis 6, 7) .
LPS is a major component of the outer membrane of gram-negative bacteria, including P. gingivalis. It has the ability to trigger a number of host cells, especially mononuclear phagocytes, to produce and release a wide variety of immunologically active mediators, including TNF-α, IL-1β, IL-6, and IL-8 8) . These cytokines have been implicated in the pathogenesis of inflammatory periodontal disease 9, 10) . In addition to these cytokines, NO has recently received considerable attention as a novel type of mediator 1) ; inhibition of NOS activity and NO production frequently limits the progression and severity of experimental inflammatory diseases such as osteoarthritis, glomerulonephritis, and colitis 11, 12) .
NO is thought to have an important role in the pathogenesis of inflammatory periodontal disease as it does in other inflammatory diseases. Enhanced production of NO has been demonstrated in periodontal disease 13) , and gingival tissues from patients with chronic periodontitis have higher levels of iNOS protein and mRNA than healthy tissue [14] [15] [16] [17] . Macrophages, polymorphonuclear cells and fibroblasts are the sources of iNOS in periodontal tissues, with endothelial cells also contributing [14] [15] [16] [17] . Moreover, LPS from Actinobacillus actinomycetemcomitans, a major pathogen of early-onset periodontitis, induced significant production of NO in macrophages 18, 19) , and LPSs from Prevotella intermedia and Prevotella nigrescens, the causative agents of inflammatory periodontal disease, fully induced iNOS expression and NO production in the murine macrophage cell line RAW264.7 cells in the absence of other stimuli 20, 21) .
The LPS of P. gingivalis may play a key role as a virulence factor in the development and progression of chronic inflammatory periodontal disease, stimulating the host cells to produce and release NO. The purpose of this study was to investigate the effects of P. gingivalis LPS on the production of NO and the expression of iNOS protein and mRNA in RAW264.7 cells, a murine macrophage cell line. We also attempted to throw light on the signaling pathway involved in the stimulation of NO production.
Ⅱ. Materials and methods 1 . Bacteria and culture conditions P. gingivalis 381 was used throughout. It was grown anaerobically on the surface of enriched Trypticase soy agar containing 5% (v/v) sheep blood, or in GAM broth (Nissui, Tokyo, Japan) supplemented with 1 μg/ml menadione and 5 μg/ml hemin. Plate grown cultures were routinely incubated for 4 days and used as the inoculum for liquid growth. Liquid-grown cells were incubated for approximately 24 h, to late exponential growth phase. They were collected by centrifugation at 12,000 × g for 20 min at 4℃, washed three times with phosphate-buffered saline (PBS, pH 7.2) and lyophilized. Culture purity was assessed by gram staining and plating on solid medium.
Preparation of LPS
To remove bioactive extracellular material, the bacteria were suspended in saline, stirred gently for 1 h at 4℃ and harvested by centrifugation. This process was repeated, and the endotoxin was extracted from the surface-washed P. gingivalis using the butanol extraction method of Morrison and Leive 22) . Briefly, cells were suspended in 0.15 M NaCl at 4℃ and an equal volume of butanol added. The suspension was mixed thoroughly at 4℃ for 10 min and centrifuged at 35,000 × g for 20 min. The aqueous phase was removed and the butanol, together with the insoluble residue, was further extracted two times with approximately half of the initial volume of saline for each extraction. The combined aqueous phases were centrifuged to remove any insoluble residues, dialysed against distilled water at 4℃ for 48 h and lyophilised. This crude preparation, which contains both lipid A-associated proteins and LPS, was re-suspended in water and ultracentrifuged for at 105,000 × g for 3 h. This procedure was repeated once more and the endotoxin lyophilised. LPS was prepared from lyophilized endotoxin by the standard hot phenol-water method 23) . Briefly, 90% phenol was added to the endotoxin suspended in pyrogen-free distilled water and the mixture was extracted twice at 68℃ for 20 min. After cooling, the aqueous phase was separated by centrifugation at 35,000 × g for 15 min and the pooled aqueous extract was dialyzed extensively against distilled water at 4℃. The dialysed extract was centrifuged at 105,000 × g for 3 h and lyophilized to yield LPS. Salmonella typhimurium LPS (phenol extract) was purchased from Sigma Chemical Co.(St. Louis, MO, USA).
Cell cultures
The murine macrophage cell line RAW 264.7 (American Type Culture Collection, Rockville, MD, USA) was grown in Nunc flasks in Dulbecco' s modified Eagle' s medium (DMEM) supplemented with 100 U/ml of penicillin, 100 μg/ml streptomycin, 10 mM HEPES, 2 mM L-glutamine, 0.2% NaHCO 3 , 1 mM sodium pyruvate, and 10% [v/v] heat-inactivated FBS in a humidified chamber with 5% CO 2 /95% air at 37 o C. At confluence, the medium and nonadherent cells were removed and replaced with fresh culture medium. After an additional 24 h of culture, the cells were harvested by gentle scraping with a rubber policeman, washed three times, and viable cells counted. The cells were seeded into 24-well culture plates at a density of 5×10 5 cells/well and incubated for at least 2 h to allow them to adhere to the plates. After washing three times with medium, various concentrations of LPS were added and the cells were cultured for the indicated times, after which culture supernatants were collected and assayed for NO.
Cytotoxicity assay
The cellular toxicity of several inbibitors was assessed by the MTT assay, which is based on the conversion of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) to formazan by mitochondrial dehydrogenases 24) . Cells were pretreated with the indicated concentrations of each inhibitor before 24 h incubation with P. gingivalis LPS (10㎍/ml). MTT was added to the cultures to a final concentration of 0.5 mg/ ml after 24 h. After incubation at 37℃ in 5% CO 2 for 2 h, the supernatant was removed and the cells were solubilized in dimethyl sulfoxide (DMSO). The extent of reduction of MTT to formazan within the cells was quantified by measuring absorbance at 570 nm with a Spectra Max 250 ELISA Reader (Molecular Devices, Palo Alto, CA, USA). Cell viability is expressed as a percentage of the control value.
Measurement of NO production
NO production was assayed by measuring the accumulation of the stable oxidative metabolite, nitrite (NO 2 -), in culture supernatants 25) . Briefly, 5×10 5 cells/well were stimulated in 24-well tissue culture plates for the indicated times, and 100 μl of Griess reagent (1% sulfanilamide, 0.1% naphthylethylene diamine dihydrochloride, and 2.5% phosphoric acid) (Sigma Chemical, St. Louis, MO, USA) was added to equal volumes of culture supernatants in a 96-well flat-bottomed microtiter plate and left at room temperature for 10 min. Optical densities at 540 nm were read with a Spectra Max 250 ELISA Reader (Molecular Devices), and nitrite concentrations were calculated from a standard curve established with serial dilutions of NaNO 2 (Sigma) in culture medium.
Western blot analysis of iNOS
Cells were plated in 60 mm tissue culture dishes at a density of 2×10 6 cells/dish and treated with various concentrations of P. gingivalis LPS for the indicated times. After incubation, they were washed three times with ice-cold PBS and lysed by incubating for 30 min on ice with 200 μl of lysis buffer (50 mM Tris·Cl [pH 8.0], 150 mM NaCl, 0.002% sodium azide, 0.1% SDS, 1% Nonidet P-40) containing protease inhibitors (1 mM PMSF, 5 mg/ml aprotinin, 5 mg/ml pepstatin A, and 5 mg/ml leupeptin). The cell lysates were centrifuged at 10,000 x g for 10 min to remove insoluble material, and their protein concentrations determined with the bicinchoninic acid (BCA) protein assay reagents (Pierce, Rockford, IL, USA) according to the manufacturer' s instructions. The same amount of protein (50 μg) from each supernatant was then subjected to SDS-polyacrylamide gel electrophoresis (SDS-PAGE) on 10% acrylamide gels with 3% stacking gels. The resolved proteins were transferred to a nitrocellulose membrane by electroblotting, and the blots were blocked for 1 h in PBST (PBS with 0.1% Tween-20) containing 3% nonfat dry milk, followed by incubation with polyclonal antibody against iNOS (Santa Cruz Biotechnology, Santa Cruz, CA, USA) diluted (1 : 50) in PBS containing 1.5% goat serum for 1 h at room temperature. They were then washed three times for 10 min each with PBST, incubated with a 1:2,000 dilution of horseradish peroxidase-conjugated goat anti-rabbit secondary antibody (Santa Cruz Biotechnology) at room temperature for 1 h and visualized by enhanced chemiluminescence (ECL) (Amersham Pharmacia Biotech, USA) as recommended. The intensity of each proteinspecific band was quantified by densitometer with densitometric software. Following incubation, they were washed twice with PBS and collected by centrifugation. Total RNA was isolated with an RNeasy Mini Kit (Qiagen, Valencia, CA, USA), according to the manufacturer' s instruc-tions. Synthesis of cDNA from the extracted RNA and subsequent amplification of the cDNA by reverse transcription-polymerase chain reaction (RT-PCR) were carried out with an AccuPower RT/PCR Premix kit (Bioneer, Korea) and thermal cycler (GeneAmp PCR system 2400; PE Applied Biosystems, Foster City, CA, USA) 26) . β-actin served as internal control. The number of cycles that ensured nonsaturating PCR conditions was established in preliminary experiments. PCR amplification of iNOS was carried out for 35 cycles of 95°C for 1 min, 62°C for 1 min, and 72°C for 1 min. The oligonucleotide primers were as follows: iNOS, 5′-TCACTGGGACAGCACAGAAT-3′′ (sense) and 5′-TGTGTCTGCAGATGTGCT-GA-3′(antisense)(corresponding to positions 348-367 and 857-838, respectively, of the published mouse iNOS mRNA sequence), yielding a 510-bp product; β-actin, 5′ -TCCTTCGTTGCCGGTCCACA-3′(sense) and 5′-C-GTCTCCGGAGTCCATCACA-3′ (antisense) (corresponding to positions 44-63 and 553-534, respectively, of the published mouse actin mRNA sequence), yielding a 508-bp product. The PCR-amplified products were run on a 1.5% aga-rose gel containing ethidium bromide and visualized with UV light. The intensities of the PCR bands on gel photographs were quantified by densitometry, and expression of iNOS mRNA was calculated as the ratio of the densities of the iNOS and actin bands. Preliminary experiments established that there was a linear relationship between total RNA levels in cell extracts (after 24 h LPS stimulation) and the density of PCR products from iNOS and β-actin mRNA (data not shown).
Statistical analysis
Statistical analysis was performed using Ⅲ. Results
NO induction by P. gingivalis LPS
Concentrations of nitrite, an indicator of NO production, were measured 24 h after adding various concentrations of isolated P. gingivalis 381 LPS to RAW264.7 cells. P. gingivalis LPS induced NO release from the RAW264.7 cells over the range 1 ng/ml to 100 ㎍/ml (Figure 1 ). Basal nitrite release was about 1 μM. It was effective at a concentration as low as 1 ㎍/ml, and maximum NO production (about 53 μM) was achieved at a concentration of 100 ㎍/ml. S. typhimurium LPS, as a control, also stimulated NO production to a maximum of 62 μM. Its activity was significantly higher than that of P. gingivalis LPS with respect of both minimum stimulatory dose and maximum NO produced.
RAW264.7 cells were challenged with 10 ㎍/ml P. gingivalis LPS, and production of NO in the culture supernatant was measured at various times thereafter. After an initial lag of 8 h, NO secretion increased linearly from 8 h to 24 h and plateaued thereafter. Nitrite accumulation reached 29 μM (Figure 2 ). S. typhimurium LPS also caused a marked elevation in NO secretion that leveled off after 24 h.
Expression of iNOS protein and mRNA
To determine whether the elevated NO production was due to upregulation of the iNOS protein, we examined the effect of P. gingivalis LPS on the expression of iNOS protein and demonstrated an increase in iNOS protein by immunoblotting. Cells stimulated with P. gingivalis LPS expressed a protein of approximately 130 kDa, recognized by specific antibody to iNOS ( Figure  3) . When RAW264.7 cells were exposed to increasing concentrations of P. gingivalis LPS, there was a concentration-dependent accumulation of iNOS ( Figure 3A) . iNOS protein was detectable with a concentration of P. gingivalis LPS as low as 0.1㎍/ml and reached a maximum at a concentration of 100 ㎍/ml. Control cells did not produce detectable iNOS band, as seen in Figure 3A . Figure 3B shows the time course of changes in iNOS protein expression induced by 10 ㎍ /ml of P. gingivalis LPS. iNOS protein showed detectable signal at 4h, and maximum expression was achieved at 12 h. (Figure 4) . When RAW 264.7 cells were exposed to increasing concentrations of P. gingivalis LPS, there was a concentration-dependent accumulation of iNOS mRNA ( Figure 4A ). iNOS mRNA was detectable with a concentration of P. gingivalis LPS as low as 0.1 ㎍/ml, reached a maximum at a concentration of 100 ㎍/ml. Control cells did not produce detectable signal, as seen in Figure 4A . Figure 4B shows the time course of changes in iNOS mRNA expression induced by 10 ㎍/ml of P. gingivalis LPS. iNOS mRNA showed detectable signal at 2 h, and maximum expression was achieved at 4 h. Unstimulated RAW264.7 cells did not contain detectable amounts of iNOS mRNA. 
Effects of various inhibitors on NO production
N G -monomethyl-L-arginine (NMMA), an L-arginine analogue, is a specific inhibitor of NO production in the L-arginine-dependent pathway 27) . To determine if the signaling mechanism of P. gingivalis LPS-induced NO production involves this pathway, RAW264.7 cells were pretreated with the indicated concentrations of NMMA for 1 h before incubation with P. gingivalis LPS. Addition of NMMA inhibited NO production in a concentration-dependent manner ( Figure 5 ).
The effect of NOS inhibitor on P. gingivalis LPS-induced NO synthesis was tested.
Cells were pretreated with the indicated concentrations of nitro-L-arginine methyl ester (L-NAME), a nonspecific NOS inhibitor, for 1 h before incubation with P. gingivalis LPS. L-NAME suppressed P. gingivalis LPS-induced NO production by RAW264.7 cells (Figure 6 ).
To elucidate the role of nuclear factor-κB (NF-κB) in P. gingivalis LPS-induced NO production, RAW264.7 cells were pretreated with 50 μM pyrrolidine dithiocarbamate (PDTC), an antioxidant that acts as a specific inhibitor of NF-κB activation, for 1 h before incubation with P. gingivalis LPS.
Pre-treatment with 50 μM PDTC produced about 94% inhibition of NO production ( Figure 7) . We also assessed whether production of NO by P. gingivalis LPS stimulation depends on microtubule polymerization. RAW264.7 cells were pretreated with 500 μM of colchicine, a mitosis inhibitor, for 30 min before incubation with P. gingivalis LPS. P. gingivalis LPS-induced NO production was found to be suppressed by colchicine pretreatment (Figure 7) . Colchicine showed about 72% inhibition of NO production at the test concentration of 500 μM without affecting cell 
viability.
To investigate the possible involvement of signaling kinases, e.g., protein tyrosine kinase (PTK) and protein kinase C (PKC), in signaling NO induction, cells were pretreated with inhibitors of these kinases for 30 min before incubation with P. gingivalis LPS. As shown in Figure. 7, the specific PTK inhibitor, genistein, showed about 67.1 % inhibition of NO production at the concentration of 10 μM. The PKC inhibitor bisindolylmaleimide also reduced P. gingivalis LPS-induced NO production by about 43.3% at the concentration of 10 μM (Figure 7 ).
Ⅳ. Discussion
Because production of NO has been recognized as a marker in a variety of human diseases associated with inflammation 28, 29) , we studied the effects of the LPS of P. gingivalis, a major cause of inflammatory periodontal disease, on the production of NO and expression of iNOS in the murine macrophage cell line RAW264.7. Macrophages are known to be the main source of iNOS in periodontal tissues 17) .
P. gingivalis LPS stimulated the release of NO from the RAW264.7 cells. Since iNOS is the catalytic enzyme of NO production 30) , we examined the effect of P. gingivalis LPS on the expression of iNOS protein and demonstrated an increase in iNOS protein by immunoblotting. iNOS is controlled mainly at the transcriptional level and we confirmed in this study that P. gingivalis LPS induces iNOS expression predominantly at the transcriptional level.
It is of interest to note that there was some delay between iNOS mRNA expression and NO production. iNOS mRNA showed detectable signals at 2 h, while NO production increased above the control level only at 12 h. Moreover, maximum iNOS mRNA expression was achieved at 4 h. Evidently, in the RAW264.7 cells, iNOS mRNA is produced at high levels, but decrease before NO reaches its maximum, and high levels of NO are found long after expression of iNOS mRNA had started to decline.
We demonstrated an absolute requirement for endogenous L-arginine in NO production. L-NAME, a non-specific NOS inhibitor, attenuated P. gingivalis LPS-induced NO production by RAW264.7 cells, indicating that the presence of NOS is a prerequisite for NO production. We also tested PDTC, an antioxidant that acts as a specific inhibitor of NF-kB activation, would affect the induction of NO by P. gingivalis LPS. NF-κB, a ubiquitous transcription factor, is known to regulate the transcription of a variety of genes involved in the inflammatory process 31) , and an increasing body of evidence has suggested that the expression of iNOS is dependent on the activation of NF-κB 4, 32, 33) . Binding of NF-κB to the specific binding nucleotide sequences in the promoter region of the iNOS gene results in rapid and effective transcription of this gene 33) . In the present study, the addition of NF-κB inhibitor, PD-TC, markedly suppressed NO synthesis indicating that NF-κB mediates P. gingivalis LPS-induced NO production in RAW264.7 cells.
We demonstrated that P. gingivalis LPSinduced NO production by RAW264.7 cells was inhibited by the microtubule-disrupting agent colchicine. Our findings suggest that microtubules are involved in NO production by macrophages activated with P. gingivalis LPS. We also examined the effect of signaling kinases. Activation of PTK and PKC appears to be necessary for P. gingivalis LPSinduced NO production in murine macrophages.
Taken together, these results indicate that multiple signaling pathways such as NF-κB, PTK, and PKC are involved in P. gingivalis LPS-stimulated NO production. It would be interesting to find out how these pathways coordinate for NO production. The inhibitors of NO production have been considered as potential anti-inflammatory agents. In this study, we evaluated the effects of various inhibitors on P. gingivalis LPS-induced NO production. As a result, PDTC showed potent inhibition of NO production without affecting cell viability (about 94% inhibition at the test concentration of 50 (M). The inhibition of NO production by PDTC may be useful in the therapy of inflammatory diseases such as periodontitis. This hypothesis, however, remains to be tested.
NO synthesis is increased in periodontal disease, as a result of macrophage infiltration in the periodontal tissues 13, 34) . The present study clearly shows that the LPS of P. gingivalis, a major periodontal pathogen, fully induced iNOS expression and NO production in the murine macrophage cell line RAW264.7 in the absence of other stimuli.
There are strain-dependent variations in the ability of P. gingivalis LPS to induce NO production. LPS from P. gingivalis ATCC 33277 failed to induce NO production by RAW264.7 cells similar to that of W50 35, 36) . In contrast, NO could be produced by murine macrophages when stimulated with LPS preparation from P. gingivalis A7436; however, this LPS was far less potent than LPS from enteric bacteria 36) . NO might play a role in the pathogenesis of both periodontitis and subsequent bone loss, either directly, or indirectly by modulating the production of other pro-inflammatory cytokines 37) . The ability of P. gingivalis LPS to promote the production of NO may be important in the establishment of the chronic lesion observed in inflammatory periodontal disease. The precise mechanism by which P. gingivalis LPS induces NO production remains to be elucidated.
